News & Updates
Filter by Specialty:
Forgoing radiotherapy possible for select postmenopausal women with early breast cancer
10 Jan 2024
byJairia Dela Cruz
For postmenopausal women with genomically defined low-risk stage I breast cancer who have been initiated on endocrine therapy immediately after breast-conserving surgery, the risk of recurrence is low despite the omission of radiation therapy, as shown in the IDEA* trial.
Forgoing radiotherapy possible for select postmenopausal women with early breast cancer
10 Jan 2024Add-on carfilzomib yields benefits in transplant-ineligible NDMM patients
10 Jan 2024
byAudrey Abella
The addition of carfilzomib to lenalidomide and dexamethasone (KRd) improved outcomes in individuals with newly diagnosed fit or intermediate-fit multiple myeloma who are transplant ineligible (NTE NDMM) as opposed to Rd only in the phase III EMN20 trial.